NeuroKai cultures living human neural tissue directly onto silicon, then gives it something to think about. Deploy code to real neurons on the NK-1 — or reach a thousand of them remotely through Vivarium. No lab required.
A neuron is self-programming, energy-frugal, and learns from a handful of examples. Digital models spend enormous resources approximating one. We start with the real thing.
Human iPSC-derived neural organoids are differentiated in-house and seated onto our microelectrode arrays. Each node is roughly half a millimetre across and carries eight bidirectional channels — enough to speak and listen at once.
A closed microfluidic loop delivers neuronal medium continuously, holding temperature, pH, and osmolarity inside a narrow band. Removing the human hand from the incubator is what took viability from hours to months.
There are no weights to update. Learning is shaped the way it is in a brain: structured electrical stimulation paired with timed neuromodulator release, delivered as predictable signal for desired behaviour and noise for everything else.
Living tissue drifts. Cultures mature, excitability shifts, nodes age out. A fixed control program cannot hold a moving substrate — so we don't use one.
NeuroKai runs on Quantum Kai, the Quantum Agentic Intelligence developed by ALIENTELLIGENCE. Kai holds persistent memory of every culture in the fleet — how a given node responded last week, which stimulation heuristics took, when a network began to fade — and orchestrates a fleet of specialised agents against that memory.
It plans the experiment, dispatches the agents, reads the spikes, and re-plans when the tissue changes its mind. No retraining cycle. No overnight queue.
Bring the substrate into your lab, or leave the biology to us and connect over the wire. Identical API either way.
A sealed, self-supporting biological computer for the bench. Life support, perfusion, recording, and compute all live inside the enclosure — plug in power and ethernet and you have a culture on your desk.
Our facility, your experiments. Reserve nodes across the fleet and run them around the clock from a notebook. We keep the tissue alive; you keep the science.
Figures are fleet medians across the trailing ninety days. Live telemetry is available to seat holders.
| Parameter | Value |
|---|---|
| Node type | Human iPSC-derived cortical organoid, ~0.5 mm |
| Channels per node | 8 bidirectional, stimulate and record |
| Sampling rate | 30 kHz per channel, continuous |
| Closed-loop latency | 6.4 ms median, 11 ms p99 |
| Median viability | 147 days · best observed 214 |
| Power per node | 0.31 W including life support |
| Perfusion | Closed microfluidic loop, 15 µL/min |
| Neuromodulation | Dopamine and serotonin, UV-uncaged, per-well |
| Interface | Python SDK · REST · streaming websocket |
| Orchestration | ALIENTELLIGENCE Quantum Kai, on-device or hosted |
| Data retention | Full raw waveform, indefinite, exportable |
Assay a compound against functioning human neural tissue and watch what it does to learning itself — not just to cell viability. Ethically superior to animal models and more predictive of the human response.
Model epilepsy, Alzheimer's, and Rett syndrome in patient-derived tissue, then perturb it continuously for months. Mechanisms that only appear over long horizons become observable.
Benchmark reinforcement learning against a substrate that adapts in real time on a rounding error of the energy. For sample-efficiency research, biology is still the state of the art.
Our cultures are small, undifferentiated relative to a brain, and possess no sensory apparatus, no body, and no capacity for suffering that current neuroscience can identify. We believe that is true. We also believe it is exactly the kind of claim that should be verified by people who do not work here.
So NeuroKai operates under an external review board with authority to halt any protocol. All tissue derives from consenting adult donors under documented IRB approval. We publish culture provenance, age limits, and termination criteria alongside every dataset, and we support the development of binding sector-wide standards before, not after, they become urgent.
Our governance framework and donor consent policy are published in full and updated quarterly.
We onboard a small number of labs each quarter and work alongside them closely. Tell us what you'd run, and we'll tell you honestly whether the substrate is ready for it.